Single-channel EEG measures stay stable over one year in healthy adults

A study published in Nature reports that single-channel EEG measures remain individually stable over a full year in healthy adults — a finding that positions simplified, low-channel recordings as candidate traits for long-term monitoring and individualized neurophysiological profiling.

The researchers followed a cohort of healthy adult volunteers across a one-year period, collecting scalp EEG from single-channel configurations rather than full conventional montages. Their core question was straightforward: do the spectral and other quantitative measures derived from one-channel recordings hold steady within the same person over twelve months, or do they drift enough to be indistinguishable from noise?

The answer, per the study, favors stability. Measures extracted from single-channel scalp EEG showed reliable within-person consistency across the repeated sessions. That individual-level stability — rather than group-level averaging — is the analytically important point: the same participant's EEG metric at month twelve resembled that participant's own baseline from month one.

For clinical neurophysiology practice, the implication is concrete. Full 10–20 montage recordings remain the standard for diagnostic work, but single-channel EEG is already migrating into wearable and consumer-adjacent hardware. If the quantitative features those devices capture are stable individual traits, they could support longitudinal tracking of medication effects, sleep architecture proxies, or early deviation from a patient's own baseline — a reference standard of one, rather than population norms.

The study population was healthy adults, not epilepsy or ICU patients. Readers in monitoring units should therefore treat the result as foundational rather than directly transferable: no claim in the study addresses seizure detection, spike yield, or ictal interpretation with single-channel hardware. The work is human data, collected with scalp EEG; it does not involve intracranial recording, ECoG, MEG, or any implantable modality.

The methodological framing also matters for anyone building longitudinal EEG databases. Trait-like stability of quantitative EEG features over one year suggests that sparse-channel recordings could serve as repeatable fingerprints in research protocols — screening cohorts, tracking pharmacological interventions, or anchoring normative libraries — provided the acquisition conditions are held constant.

The authors' analysis emphasized individual consistency across the annual interval. This distinguishes the work from earlier test–retest EEG reliability studies focused on shorter windows or on dense montages, and it extends the evidence base to a minimal-hardware configuration.

What the study did not do is equally clear. It did not test clinical populations, did not validate any specific commercial wearable, and did not establish diagnostic utility. The demonstrated claim is narrower: in healthy adults, single-channel scalp EEG measures are individually stable over one year.

Future work will need to establish whether this stability holds in patient groups and whether single-channel trait measures can flag clinically meaningful change — questions the study's one-year healthy-adult baseline now makes testable.